Among his awards are the Distinguished Alumnus Award from Tulane School of Medicine; Life Achievement Awards from European Society of Cardiology, Japanese Circulation Society and Israeli Heart Society; American Heart Association Heart and Stroke Award, Morgagni Award (Padua, Italy), Simon Dack Scholarship Award, and Distinguished Clinical Scientist Career Award (American College of Cardiology) in 2008.

Dr. Maron has authored 860 original peer-reviewed articles, book chapters and other contributions to the literature, as well as 325 abstracts and 7 books including the well-regarded “Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians”.

Research initiatives have included diverse clinical and pathologic aspects of hypertrophic cardiomyopathy over a 40 year career, including development of risk stratification guidelines and introducing implantable defibrillators for effective prevention of sudden death in adults and children with this hypertrophic cardiomyopathy. In addition, a new segment of cardiovascular medicine has been developed defining the causes of sudden death in trained athletes (including ventricular fibrillation due to blunt chest blows [commotio cordis]), strategies for preparticipation screening, and criteria for disqualification vs. eligibility with cardiovascular abnormalities.